anti inflammatory drugs modified summary
TRANSCRIPT
Mediators of Inflammation
and Anti-inflammatory
Drugs
Done by: Dr. Noor Najjar
InflammationMediators of inflammationNSAIDsOpoids Combination Analgesia
Outline
CAUSE OF INFLAMMATION
Inflammation typically represents the response to tissue injury and includes products of activated mast calls, leukocytes, and platelets.
The clinical features of inflammation include1. tumor (edema)2. rubor (redness)3. Calor (heat)4. dolor (pain)5. loss of function.
Inflammation can be divided into three phases:a) Acute inflammation Inflammatory mediators such as histamine are
released.
b) Subacute inflammationInflammatory cells migrate and invade the site. PGs, leukotrienes, platelet-activating factor
(PAF), and cytokines are prominent in this stage.
c) chronic inflammation.lymphocytic phase of injury cleansing and repair. Cytokines, especially interleukins and tumor
necrosis factor-α (TNF-α), are prominent in this stage .
In reality these phases are not distinct entities. Components of the subacute phase participate in the acute inflammatory process, and acute inflammatory mediators are present in chronic inflammatory disorders.
1HistamineProstaglandinsLeukotrinesLysosomal productsLymphocyte productsMacrophage productsMast cell productsEosinophile products Plasma protein derived Mediators Nitric Oxide
Tissue mediators
Tissue Mediators1. HistamineHistamine is the first mediator which has a
role in the inflammatory process.Most of the histamine is stored in mast cells
and basophilic granules, only some of it exists as free active in tissues.
Various physical and chemical stimuli -antigens, complement fragments, or simple mechanical trauma- causes extrusion of the granules and release of active histamine into the extracellular fluid.
Histamine causes:I. dilation of vessels of the microcirculation II. Marked but transient, increase in the
permeability of capillaries and post-capillary venules.
The histamine content of tissue fluid at the site of injury increases within minutes after the insult and then decreases gradually.
Antihistamines have little use as general anti-inflammatory agents. However, antihistamines that block the H1 receptor are useful in reducing symptoms attributable to histamine in allergic reactions.
2. ProstaglandinsPGs are derived from arachidonic acid. Also can be
generated by inflammatory cells.PGs exert a multitude of effects in almost every
biologic process :A. smooth muscle contraction and relaxationB. vascular permeabilityC. renal electrolyte and water transportD. gastrointestinal (GI) and pancreatic secretionE. various CNS and autonomic nervous system
functionsF. release of hormonesG. Bone resorptionH. Platelet aggregation
PGs are being formed and released at times when tissue damage and disintegration are more prominent especially during phagocytosis.
PGI2 and PGE2 are potent inducers of vasodilation and of increased vascular permeability, which may last for several hours.
PGE2 is pyrogenic, suggesting a mediator function.
Certain anti-inflammatory drugs that are potent inhibitors of PG synthesis reduce experimentally produced inflammation.
All cells except erythrocytes can convert arachidonic acid to PGs and related compounds by the action of COX.
A balance between enhancement and suppression of inflammatory events could be achieved by local regulation of PG metabolism because in some systems PGs have been shown to be either stimulatory or inhibitory depending on their concentration.
COX-1: constitutive enzyme: is involved in tissue
homeostasis.
COX-2: inducible enzyme: is responsible for the
production of the prostanoid mediators of inflammation
COX
COX Enzyme:Prostaglandin Effects
COX-1: beneficial COX-2: harmful
Peripheral injury site
Inflammation
Brain Modulate pain perceptionPromote fever (hypothalamus)
Stomach protect mucosa
Platelets aggregation
Kidney vasodilation
3.LeukotrienesThe ability of cells to produce leukotrienes seems to be limited
tothe lung, leukocytes, blood vessels, and epicardium.Leukotrienes C4 and D4 are constrictors of bronchial smooth
muscle More potent than histamine-they increase vascular
permeability Leukotriene B4 can enhance chemotactic and chemokinetic
responses in human neutrophils, monocytes, and eosinophilsThey are involved in localized inflammatory processes and in
asthma.Drugs that block leukotriene receptors or inhibit leukotriene
synthesis by blocking the enzyme lipoxygenase are used in the treatment of asthma.
4.Lysosomal productsDuring phagocytosis of bacteria or foreign material by
neutrophils, the contents of lysosomes are released into the extracellular environment.
Cationic proteins released contribute to the inflammatory process by triggering mast cell degranulation increased vascular permeability
Several of these enzymes have the potential to damage host tissues.
Collagen, elastin, mucopolysaccharides, basement membrane, and other structural elements may be degraded.
Lysosomal proteases cause the production of kinin-like substance and can generate chemotactic factors for neutrophils from complement
5.Lymphocyte products
Delayed allergic reactions may be involved in some inflammatory processes, especially chronic processes in which there is a persistent antigenic stimulus. These reactions are mediated by factors called cytokines (lymphokines if derived from lymphocytes), which are produced by sensitized thymus-dependent lymphocytes, or T cells, after specific antigenic challenge.
Cytokines that may function in inflammation related events are:
(1) Interleukins that stimulate the function of T&B cells. (2) Monocyte chemoattractive protein-1, which
promotes accumulation of monocytes. (3) Granulocyte/macrophage colony stimulating
factor. (4) Other chemotactic factors that are specific attractants
for neutrophils, macrophages, basophils and eosinophils. (5) Interferon-á, which has antiviral and macrophage
activation properties.(6) Skin reactive factor, which mimics a delayed allergic
reaction when injected into normal skin.
6.Macrophage productsThey have Little involvement in acute
inflammatory responses, but they play a very prominent role in chronic inflammation and are crucial in the immune response.
Secretory products includea) The constituents of lysosomes b) Reactive metabolites of oxygenc) Interferon-á, interleukin-1 (IL-1), and TNF-á.
IL-1 is produced by macrophages exposed to bacterial, viral, and fungal products; antigens; or macrophage activation factor.
Main role is stimulation of differentiation of a pre–T lymphocyte population to T cells capable of responding to an antigen processed and presented by macrophages.
PAF is a mediator of inflammation produced by macrophages, mast cells and eosinophils and Platelets.
PAF initiates various actions:A. Platelet activationB. VasodilationC. Vascular permeabilityD. Neutrophil chemotaxis E. Discharge of lysosomal enzymes. F. Contributes to allergic and inflammatory responses.
7.Mast cell productsMast cells release numerous inflammatory
mediators 1. histamine2. cytokines (e.g., TNF-á)3. leukotrienes4. PGD25. PAF. Mast cells can become activated by IgE
antibodies that bind to the plasma membrane and sensitize the mast cell to specific allergens. Several allergic reactions, including allergic asthma, involve this mechanism.
Basophiles have many of the same characteristics as mast cells.
8.Eosinophil productsEosinophils release many enzymes and toxins that can lead to tissue destruction.
Major basic protein is a toxic substance that can cause tissue damage and destruction of parasites.
Eosinophils also release leukotrienes and PAF.
9.Plasma MediatorsKininsThe term kinins refers primarily to two small
peptides that are similar in structure and actions: bradykinin and lysylbradykinin
As with the release of histamine, almost any process causing tissue injury can trigger the series of events leading to the production of bradykinin.
Bradykinin exists in plasma as an inactive precursor (kininogen) and is released in a cascade of reactions.
After release, bradykinin is rapidly metabolized by enzymes present in plasma and tissues.
Bradykinin is a potent but transient vasodilator of arteries and veins by a direct action on smooth muscle.
10.Nitric Oxide (NO)
NO plays a regulatory and a pro-inflammatory role in various inflammatory conditions, including arthritis, asthma, and inflammatory bowel disease.
Currently approved drugs that target the nitric oxide system, such as nitroglycerin to treat angina and the male erectile dysfunction drug sildenafil (Viagra) increase NO levels.
Analgesics should be used judiciously in dental care as a temporary measure until the cause of pain has been dealt with.
The choice of an analgesic should be based on its suitability for the patient.
Most dental pain is relieved effectively by NSAIDs.
Analgesics are classified as 1. Non-opioid analgesics2. Opioid analgesics3. NSAIDs4. Neuropathic pain agents5. Antimigraine drugs
Analgesics
Non selective COX inhibitors:Salicylates: AspirinPropionic acid derivatives : Ibuprofen, ketoprofen, flurbiprofenFenamate: Mephanamic AcidEnolic acid derivatives: piroxicam, TenoxicamAcetic acid derivative: Ketorolac, IndomethacinPyrazolone derivatives: Phenylbutazone, OxyphenbutazonePerferential COX-2 inhibitors:Nimesulide, Diclofenac, Aceclofenac, Meloxicam, EtodolacSelective COX-2 inhibitors:Celecoxib, etoricoxib , ParecoxibAnalgesic-Antipyretic with poor antiinflammatory action:Paraaminophenol derivatives : paracetamol Pyrazolone Derivatives: propiphenazoneBenzoxazocin derivatives : Nefopam
Classification of NASIDS
For Acute Pain (e.g dental procedures) short term use ≤1 week highly efficacious and safe.
For chronic inflammatory conditions months or years with doubling the dose often 2-3folds.
NSAIDs lack various undesirable CNS depressant effects that contribute to the high incidence of drowsiness, dizziness, and nausea commonly seen with opioid-containing agents.
The development of NSAIDs that are highly selective COX-2 inhibitors seemed to offer a safety advantage regarding some of the more serious adverse effects seen with long term NSAID therapy, specifically GI ulcers, perforations, and bleeds.
Major Actions: ANALGESIA , ANTIPYRETIC , ANTI-INFLAMMATORY Except acetaminophen
Non steroidal anti-inflammatory
NSAIDs : anti-platelet—decreases ability of blood to clot
Effects of COX Inhibition by Most NSAIDS
It was first extracted in 1835 from natural sources and later prepared by chemical synthesis.
Aspirin was synthesized from salicylates (acetylsalicylic acid) by treating sodium salicylate with acetyl chloride.
It is one of the most consumed drugs in the world.
Salicylates
Mechanism of action
The efficacy of salicylates and all related NSAIDs as analgesic, anti-inflammatory, and antipyretic agents results from:
Their ability to inhibit COX activity, preventing the synthesis and release of COX products, most prominently the PGs
Note : All salicylates and almost all the currently available NSAIDs, with the exception of the highly selective COX-2 inhibitors, inhibit COX-1 and COX-2.
• Most of these non selective COX inhibiting NSAIDs, including aspirin, are more potent or at least equipotent inhibitors of COX-1 which accounts for some of the more important adverse effects of these drugs.
• Aspirin is an approximately 100-fold more selective inhibitor of COX-1 than COX-2.
Salicylates may inhibit cell migration and some functions of neutrophils.
Salicylates Suppress T cell activity Causes reduction in rheumatoid factor (RF) production.
Other mechanisms contributing to anti-inflammatory effects include reduced capillary permeability, reduced antibody production, and alterations in connective tissue synthesis.
Inhibition of PG synthesis at the site of injury or inflammation can explain at least some of the analgesic effect of aspirin. Although PGs themselves do not seem to cause pain when injected locally, PGE2 and PGF2α do sensitize pain receptors to other mediators such as histamine and bradykinin.
In this connection, aspirin and related drugs can prevent the writhing response elicited by bradykinin but not that produced by PGs. This finding is explained by the fact that the salicylates and all other NSAIDs inhibit the synthesis of PGs induced by bradykinin but not the binding of PGs to their receptors. Animal experiments have revealed that NSAIDs also have central analgesic actions, which may involve the inhibition of COX or other unknown mechanisms at the level of the spinal dorsal horn or at higher levels of the CNS.
Salicylate is distributed throughout most body fluids & tissues. It can be isolated from spinal, peritoneal, and synovial fluids; saliva; breast milk; and sweat.
Salicylate freely crosses the placenta from mother to fetus.
Half-life of sodium salicylate is 2-3 hours after single analgesic dose.
Aspirin
General therapeutic effects
Aspirin has clinically useful analgesic, antipyretic, antiinflammatory, and antiplatelet effects.
1. Analgesic effect sought and attained with aspirin is probably caused in many cases by its anti-inflammatory actions.
Symptomatic relief of acute pain and fever.
Treatment of numerous chronic inflammatory diseases.
2. Antipyretic action
• Fever occurs when the set-point of the anterior
hypothalamic thermoregulatory center is elevated.
• This can be caused by PGE2 synthesis, which is
stimulated when an endogenous fever-producing agent
(pyrogen), e.g: cytokine, is released from white cells that
are activated by infection, hypersensitivity, malignancy, or
inflammation.
• The salicylates lower body temperature in patients with
fever by impeding PGE2 synthesis and release.
3. Antiplatelets effects (anticoagulant effect) Low doses of aspirin can irreversibly inhibit thromboxane (enhances
platelet aggregation) production in platelets.
Because platelets lack nuclei, they cannot synthesize new enzyme, and
the lack of thromboxane persists for the lifetime of the platelet (3-7 days).
As a result of the decrease in TXA2, platelet aggregation is reduced,
producing an anticoagulant effect.
Aspirin also inhibits cyclooxygenase in endothelial cells, resulting in
reduced PGI2 (decreases platelet aggregation) formation
Endothelial cells possess nuclei able to re-synthesize new
cyclooxygenase. Therefore, PGI2 is available for antiplatelet action.
Normal physiologic interaction between PGI2 and TXA2 in platelet and endothelial cell biology
Blood Vessel WallEndothelial Cell (COX-2)
Ca2+/vessel smooth muscle constricts
Arachidonic acid
PGH2
Prostacyclin (PGI2)
cAMP/vessel smooth muscle relaxes
Arachidonic acid
PGH2
Thromboxane (TXA2)
cAMP aggregation
Ca2+ aggregation
Platelet (COX-1)
• Respiratory actions
At therapeutic doses, aspirin increases alveolar ventilation.
Higher doses work directly on the respiratory center in the medulla, resulting
in hyperventilation and respiratory alkalosis that usually is adequately
compensated by the kidney.
At toxic levels, central respiratory paralysis occurs, and respiratory acidosis
results due to continued production of CO2.
• Gastrointestinal effects Epigastric distress, ulceration, haemorrhage, and iron-deficiency anaemia.
Due to inhibition of PGE2 (stimulate synthesis of protective mucus in both
the stomach and small intestine.
Misoprostol (PGE1-derivative) and the proton-pump inhibitors (lansoprazole,
omeprazole) can also be used for the treatment of an NSAID-induced ulcer.
• Actions on the kidney
Cyclooxygenase inhibitors prevent the synthesis
of PGE2 and PGI2-prostaglandins that are
responsible for maintaining renal blood flow.
Decreased synthesis of prostaglandins can result
in retention of sodium and water and may cause
edema and hyperkalemia in some patients.
USES:1. Acute pain. It is difficult to separate the analgesic
and anti-inflammatory Effects of NSAIDs because most painful
conditions have an inflammatory component.
Aspirin is an effective analgesic for almost any type of acute dental pain.
There is a dose-response for pain relief up to 650 to 1000 mg of aspirin, but increasing the dose beyond these amounts does not enhance the analgesic effect further and does INCREASE the likelihood for toxic effects.
2.Rheumatic fever. One of the early uses of salicylates was in
the treatment of rheumatic fever. Aspirin markedly reduces the acute inflammatory
components of the disease, such as fever, joint pain, swelling, and immobility. Salicylates do not affect other aspects of the disease, however, such as the proliferative reaction in the myocardium leading to scarring, and they do not alter the progression of the disease.
Although anti-inflammatory drugs, including corticosteroids may be used to reduce inflammation, antibiotic therapy is the major therapeutic strategy.
3.Fever4.Prophylaxis against platelet aggregation
5. Rheumatoid arthritis.Salicylates are the drug of choice in the
treatment of rheumatoid arthritis. In larger dose they suppress the swelling,
immobility and redness of the joints involved. They produce relief in pain, swelling and
morning stiffness in the rheumatoid arthritis patients.
Absorption, fate, and excretionWhen aspirin is taken orally, it is rapidly absorbed from the
stomach and small intestine. Aspirin is a weak acid, with a pKa of approximately 3.5, which
favors its absorption in the stomach. Most absorption occurs in the small intestine
Half life : Dose-dependent; 2–3 hours for low doses, 15–30 hours for large doses
Because its acetylation of COX in the platelet is irreversible, however, the full extent of its antiplatelet action depends on the life span of the platelet (8 days) and not on the short half-life of aspirin.
It is quickly metabolized by gastric and plasma esterases to salicylate ion .
Although some aspirin becomes bound to plasma proteins, 80% to 90% of the salicylate ion is bound for a short time, principally to albumin.
The liver is the main site of biotransformation, and conjugation is the primary route.
Adverse effectsDepend on the overall health of the patient, the
length of dosing, and the total daily intake of drug.
• GITEpigastric distress, nausea, and vomiting. Aspirin is an acid and at stomach pH, aspirin is
uncharged; consequently, it readily crosses into mucosal cells, where it ionizes (becomes negatively charged) and becomes trapped, thus potentially causing direct damage to the cells.
• Respiration In toxic doses, salicylates cause respiratory depression.
Allergic reactions include urticaria, skin rash, rhinorrhoea, asthmatic attack and anaphylactic reactions.
• Blood inhibition of platelet aggregation and a prolonged
bleeding time aspirin should not be taken for at least 1 week prior to
surgery.
Contraindications and precautionsDISEASE STATE Possible adverse effect of
aspirin Ulcer Internal bleeding , possible
haemorrhage Compromised liver Function((Hypocoagulation states))
Excessive bleeding
Asthma patientse.g : patients with nasal polyps
Asthmatic attacks resemble allergic reaction
Diabetic High dose may cause hypoglycaemia or hyperglycaemia (Salicylates may also increase insulin secretion)
Gout Low plasma increase plasma urate high dose decrease plasma urate
Children < 16 yrs Reye's syndrome **
viral infection (influneza) in adolescent
Reye's syndrome
aspirin intolerance Allergic reaction
pregnancy and elderly.
Reye's Syndrome :Is primarily a children's disease, although it can occur at any
age. It affects all organs of the body but is most harmful to the
brain and the liver--causing an acute increase of pressure within the brain and, often, massive accumulations of fat in the liver and other organs.
The disorder commonly occurs during recovery from a viral infection, although it can also develop 3 to 5 days after the onset of the viral illness.
Symptoms of RS include 1. persistent or recurrent vomiting.2. Listlessness.3. personality changes such as irritability, disorientation or
confusion delirium, convulsions, and loss of consciousness.
DosageAs analgesic and antipyretic:
0.3-0.6gm, 6-8 hourlyAcute rheumatic fever:
75-100mg/kg/day in divided doses/4-6 days 50mg/kg/day/2-3wks- maintenance dose
Rheumatoid arthritis: 3-5gm/day
Cardio protective: 80-100mg/day
Mild-moderate dental pain: 650 to 1000 mg
.
OverdoseOverdose Acute overdose has a mortality rate of 2% Chronic overdose more lethal with mortality rate 25%
especially in children No antidote for aspirin poisoning.
Acute toxic dose > 150mg/kg Chronic toxicity of doses of 100mg/kg
Lethal dose >500mg/kg Overdose/acute salicylate poisoning is characterized by
salicylism which consists of:1. tinnitus2. vertigo and deafness 3. hyperthermia4. toxic encephalopathy (agitation, confusion and convulsions
followed by coma)5. dehydration (due to hyperpyrexia, sweating and vomiting),6. disturbances of acid base balance 7. petechial haemorrhages.
Treatment of Overdose/Toxicity (Salicylate Poisoning)Treatment
i. Gastric lavage. ii. Intravenous fluid to correct dehydration.
iii. Cold water/alcohol sponges for hyperthermia.iv. To prevent intracellular potassium loss, potassium is given along with sodium bicarbonate.v. For ketoacidosis and hypoglycemia, glucose may be given.
vi. In severe intoxication, dialysis (peritoneal dialysis and haemodialysis) may be used.
Diflunisal is a difluorophenyl derivative of salicylic acid with anti-inflammatory, analgesic, and antipyretic activity. Although structurally related to salicylates but diflunisal is not hydrolyzed in vivo to salicylate and is unique among the salicylates.
Similar to other salicylates, diflunisal blocks the synthesis of PGs by inhibiting COX.
Diflunisal is approximately 10-fold more potent than aspirin in suppressing PG formation in rats.
The drug is well absorbed after oral administration, with peak blood concentrations occurring in 2 to 3 hours. It is highly bound to plasma protein. Diflunisal has a long plasma half-life (8 to 12 hours versus 2.5 hours for salicylate). The drug is excreted in the urine
Diflunisal
USES: 1. Mild-Moderate pain for osteoarthritis 2. rheumatoid arthritis3. postoperative dental painBecause diflunisal has an extended duration of action and a
relatively slow onset of action in acute pain models so the recommended dosage regimen is a 1000-mg loading dose followed by 500 mg every 8 to 12 hours
Adverse Effects4. Nausea and epigastric pain to peptic ulcer and GI bleeding.5. Diflunisal prolongs the prothrombin time in patients
receiving oral anticoagulants, perhaps by competitive displacement of coumarins from protein binding sites.
Note: Diflunisal does not penetrate the blood-brain barrier as well as aspirin does, and diflunisal causes fewer CNS effects, including tinnitus.
For this same reason, it is not used as an antipyretic.
Many NSAIDs chemically unrelated to the salicylates are now available. They all inhibit COX, but they vary in their relative potencies against COX-1 and COX-2.
Some NSAIDs may have other anti-inflammatory actions in addition to inhibiting COX.
For more long-term use, as in the treatment of rheumatoid arthritis, the choice of an NSAID for therapy is largely empiric and often based on what drug is best tolerated and best relieves symptoms in the individual patient. Most of these drugs are arylalkanoic or heteroarylalkanoic acid derivatives.
Other NSAIDs
Possess anti-inflammatory property similar to aspirin but toxicity and adverse effects are fewer and of lesser intensity.
These preparations alone and in combination with other NSAIDs are used for treatment of inflammatory disorders muscle spasm and rheumatic disorders.
They are all well absorbed orally and are highly bound to plasma proteins (90-99%).
Metabolized largely in liver Excreted in urine as well as in bile.Indication : in rheumatoid and osteoarthritis,
ankylosing spondylitis, mild to moderate pain including dysmenorrhoea, soft tissue injuries, fractures and postoperative analgesia.
Propionic acid derivatives
1. Ibuprofen2. Naproxen3. Fenoprofen.4. Oxaprozin.5. Ketoprofen6. Flurbiprofen7. Ketorolac.8. Etodolac9. Sulindac.
Propionic acid derivatives
first single-entity oral analgesic with a greater peak analgesic effect more than 650 mg of aspirin.
Anti-inflammatory, analgesic and antipyretic properties.
Fewer side effects than other NSAID but weaker anti-inflammatory.
Ibuprofen administered preoperatively or immediately postoperatively can delay the onset and lessen the severity of postoperative pain.
Dose: 400 to 600 mg every 4 to 6 hoursMaximum daily dose of 2400 mg.Ibuprofen is a weak organic acid and is highly bound to plasma
albumin. It is extensively metabolized and excreted in urine.Half life of approximately 2 hours. BRUFEN, FENBID, DOLARAZ
1.Ibuprofen:
After oral administration, it is fully Absorbed. It is 99% bound to plasma proteins and crosses
placenta.Partially metabolized , & the metabolites of naproxen
are excreted in urine. Naproxen is more efficacious and better tolerated. It is also longer acting and has the advantage of twice
daily dosing.The sodium salt of naproxen at a 220-mg dose with a
maximum recommended daily dose of 660 mgNaproxen is more irritating to the GI tract than
ibuprofen.
NO PAIN
2. Naproxen
Ketorolac was the first injectable NSAID approved in the United States.
Also available in tablet form for oral use, but only after initial intramuscular or intravenous injection.
The total course of therapy with ketorolac not exceed 5 days. Because the drug’s high incidence of GI ulceration and bleeding complications compared with other NSAIDs.
Indications: in postoperative pain management in patients who are unable to consume oral analgesics or when the pain is severe and injectable opioids are contraindicated.
3.Ketorolac
Adverse effects of propionic acid Although the incidence with some propionic
acid disturbances (epigastric pain, nausea, vomiting, gastric bleeding, and constipation or diarrhea) can occur.
These drugs should be used with caution in patients with a history of peptic or duodenal ulcer.
Long-term, high-dose administration for arthritic conditions is far more likely to produce serious adverse events than short-term administration for acute pain.
CNS effects May include headache, dizziness, drowsiness,
vertigo, and visual and auditory disturbances including tinnitus.
Renal Effects Little effect on normal kidneysNSAIDs Promote Na RETENTION When renal blood flow is impaired as in: Heart failure Dehydration Kidney disease Normal agingSkin rashes are common, and immediate allergic
reactions have been reportedIncreased risk of GI bleeding when these drugs and
other NSAIDs are taken concomitantly with antidepressants of the selective serotonin reuptake inhibitor (SSRI) class.
Name Time to peak (hours)
½ life parent ½ life*active
Aspirin 1-2 0.25-0.33 (*3-10 L-H)
Naproxen 2-4 12-15 Oxaprozin 3-5 42-50*Sulindac (pro-drug) 2-4 7.8
(*16.4) Ketorolac (inj) .5-1 3.8-8.6 Ibuprofen 1-2 1.8-2.5
Pharmacokinetic Variability of Non-Selective COX-Inhibitors
Examples areA. CelecoxibB. rofecoxib, C. ValdecoxibD. KETOROLACE. NIMESULIDEF. NABUMETONE
The selectivity of these so-called coxibs led to roughly a 50% to 60% reduction in serious GI complications—including symptomatic ulcers and GI bleeds, perforations, and obstructions compared with standard NSAIDs (e.g., ibuprofen, naproxen, diclofenac)
Selective COX-2 Inhibitors
Greater affinity for cyclooxygenase-2Decreased incidence of negative effects
associated with non-selective COX-inhibitors
Name Time to peak (hours)
½ life (hours)
Celecoxib 3 11
Rofecoxib 2-3 17
Selective COX-2 Inhibitors cont’
Adverse effects:1. nausea2. vomiting 3. dyspepsia 4. abdominal pain 5. diarrhoea6. edema of the lower extremities
Share some of the renal adverse effects of non selective COX inhibitors and renal toxicity
Hence their use should be restricted to patients who do not tolerate other NSAIDs
Selective COX-2 Inhibitors cont’
Actions 1. Acts on CNS to produce analgesia and antipyretic effect. 2. It also raises the pain threshold.It has negligible anti-inflammatory action peripherally in
therapeutic uses. It is poor inhibitor of PG synthesis in peripheral tissues, but
more active on COX in brain. Paracetamol is given orally and is well absorbed, peak plasma
concentration is reached in 30 to 60 minutes.Excreted in URINEInactivated in LIVER. Acute toxicity may result in hepatic failure.Paracetamol is used for the rapid relief of fever, pains and
aches such as headache, earache, toothache, fibrositis, myalgia, neuralgia, arthralgia, osteoarthritis and postoperative pain.
Para aminophenol DerivativesACETAMINOPHEN/PARACETAMOL
Adverse EffectsThe potential for adverse effects from acute or chronic
overdose with the drug. At therapeutic doses, acetaminophen does not cause nausea,
inhibit platelet aggregation, prolong prothrombin time, or produce the other side affects associated with the use of aspirin or NSAIDs.
Allergy to acetaminophen is rare and is generally manifested as skin eruptions.
Acetaminophen rarely has been associated with neutropenia, thrombocytopenia, and pancytopenia.
In contrast to phenacetin, acetaminophen rarely produce methemoglobinemia
At recommended therapeutic doses (500-1000mg) in healthy subjects is well tolerated
Hepatic and renal toxicity:Larger doses (7-10gm) produce extensive hepatocellular damage
and renal tubular necrosis, and may cause death
This is a major problem in paracetamol poisoning Liver toxicity is due to N-acetyl-P- benzoquinone imine which normally turns
harmless by conjugation with glutathione Early manifestations are just nausea, vomiting, abdominal pain and live
tenderness with no impairment of consciousness After 12-18hrs centrilobular hepatic necrosis occurs which may be accompanied
by renal tubular necrosis and hypoglycemia that may progress to coma
Treatment: Patient is brought early (within 16hrs of ingestion) Vomiting should be induced or gastric lavage done Activated charcoal is given orally or through tube to prevent further absorption Other supportive measures, as needed, should be taken
Specific: N- acetylcysteine 150mg/kg should be infused i.v. over 15min, followed by the
same dose i.v. over next 20hrs
Para aminophenol Derivatives Cont..
Diclofenac:Probably has greater activity than other NSAIDsExtensively bound to plasma proteins, t1/2 is 1-2hrsAccumulates in the synovial fluid- probably responsible
for its longer duration of action than its t1/2
Incidence of adverse reactions is 20%Adverse effects similar to propionic acid derivatives +
elevation of liver enzymes
Arylacetic acid Derivatives
Mefenamic acid:Useful in chronic and dull aching painsNo advantages over other NSAIDsWeaker analgesic than aspirinAdverse reactions include gastric upset, diarrhoea,
dizziness, headache, skin rashes, hemolytic anemia
Dose is 500mg 2-3 times a dayUsed in Dysmenorrhoea
Anthranilic acid Derivatives (Fenamates)
Diclofenac 1% gelIbuprofen 10% gelNaproxen 10% gelKetoprofen 2.5% gelFlurbiprofen 5% gelNimesulide 1% gelPiroxicam 0.5% gel
Topical NSAIDs
DEFINITION:
• Any natural or synthetic compound that imitates properties of natural narcotics
Is an analgesic that works by binding to opioid receptors, which are found principally in the central nervous system and the gastrointestinal tract.
The receptors mediate both the beneficial effects, and the undesirable side effects.
Opoids
ExamplesMorphineHeroinHydromorphoneFentanylCodeine
Natural opiatesAlkaloids contained in the resin of the opium
poppy (morphine, codeine, thebaine)Semi-synthetic opiates
Created from the natural opioids (hydromorphone, hydrocodone, oxycodone,oxymorphone, desomorphine, diacetylmorphine (Heroin)
Fully synthetic opioidsCreated from chemical compounds (fentanyl,
pethidine, methadone, tramadol and propoxyphene)
Endogenous opioid peptides Produced naturally in the body (endorphins,
enkephalins, dynorphins, and endomorphins)
Opoids/ CLASSIFICATION
Distribution - Widely distributed throughout body tissue; concentration in kidney, liver and spleen is higher than that in plasma.
Only a small fraction enters brain rather slowly. Morphine crosses placenta. Metabolism - Extensively in the liver. Excretion - Metabolites are excreted by the kidneys. A small fraction
is excreted in stool through the biliary tract.
Routes of administration - Oral, Transmucosal, I.V (most rapid acting), I.M and S.C
LATENCY TO ONSETi. oral (15-30 minutes)ii. intranasal (2-3 minutes)iii. intravenous (15 – 30 seconds)iv. pulmonary-inhalation (6-12 seconds)
DURATION OF ACTION – anywhere between 4 and 72 hours depending on the substance in question.
Opoids/PHARMACOKINETICS
They reduce pain by binding to receptor sites (mainly mu-receptors) in the central and peripheral nervous system. After stimulation of receptors they mimic the effects of naturally occurring opiates that are apart of the body's own pain relief system.
Processing of pain information is inhibited by a direct spinal effect at the dorsal horn, which involves presynaptic inhibition of the release of tachykinins like substance P.
Emotional response to pain altered by opioid actions on the limbic cortex
Act presynaptically to block Ca2+ uptake and consequently inhibit neurotransmitter release. Opioids have been shown to inhibit the release of many neurotransmitters, including substance P, acetylcholine, norepinephrine, glutamate, and serotonin.
Opoids/PHARMACODYNAMICS
1. relieve severe pain in acute, chronic and
terminal illnesses. 2. Reduce anxiety3. Control diarrhea4. Suppress coughing.
Opoids/PPHARMACOTHERAPUTICS
ACUTE Chronic MiosisRespiratory DepressionNausea and vomitingSedationSkeletal muscle hypertonusEuphoriaConstipationVasodilatationUrinary retentionBradycardiaBiliary SpasmMorphine poisoning
Tolerance Physical Dependence Apnea (in newborns)
Opoids/ADVERSE EFFECTS
1.Sedation and anxiolysisDrowsiness and lethargyApathyCognitive impairmentSense of tranquility
2.Depression of respirationMain cause of death from opioid overdoseCombination of opioids and alcohol is especially
dangerous
3.Cough suppressionOpioids suppress the “cough center” in the brain
4. Pupillary constrictionpupillary constriction in the presence of analgesics
is characteristic of opioid use
Opoids/Pharmacological Effects
5.Nausea and vomitingStimulation of receptors in an area of the medulla called
the chemoreceptor trigger zone causes nausea and vomiting
Unpleasant side effect, but not life threatening
6.Gastrointestinal symptomsOpioids relieve diarrhea as a result of their direct actions on
the intestines
7.Other effectsOpioids can release histamines causing itching or more
severe allergic reactions including bronchoconstrictionOpioids can affect white blood cell function and immune
function
Opoids/Pharmacological Effects cont
OpoidsTolerance and Dependence
Tolerance Tolerance is a diminished responsiveness to the
drug’s action that is seen with many compoundsTolerance can be demonstrated by a decreased
effect from a constant dose of drug or by an increase in the minimum drug dose required to produce a given level of effect
Physiological tolerance involves changes in the binding of a drug to receptors or changes in receptor transductional processes related to the drug of action
This type of tolerance occurs in opioids
DependencePhysiological dependence occurs when
the drug is necessary for normal physiological functioning – this is demonstrated by the withdrawl reactions
Withdrawl reactions are usually the opposite of the physiological effects produced by the drug
Withdrawl ReactionsAcute Action
Analgesia Respiratory Depression Euphoria Relaxation and sleep Tranquilization Decreased blood pressure Constipation Pupillary constriction Hypothermia Drying of secretions Reduced sex drive Flushed and warm skin
Withdrawl Sign Pain and irritability Hyperventilation Dysphoria and depression Restlessness and insomnia Fearfulness and hostility Increased blood pressure Diarrhea Pupillary dilation Hyperthermia Lacrimation, runny nose Spontaneous ejaculation Chilliness and “gooseflesh”
Dependence continuedAcute withdrawl can be easily precipitated
in drug dependent individuals by injecting an opioid antagonist such as naloxone or naltrexone – rapid opioid detoxification or rapid anesthesia aided detoxification
The objective is to enable the patient to tolerate high doses of an opioid antagonist and undergo complete detox in a matter of hours while unconscious
After awakening, the person is maintained on orally administered naltrexone to reduce opioid craving
1.MorphinePHARMACOKINETICSRoutes of administration (preferred) a. Oral latency to onset –(15 – 60
minutes ) b.sniffed c. injected. Duration of action :( 3 – 6 hours) First-pass metabolism results in poor
availability from oral dosing. 30% is plasma protein bound
AGONIST for mu, kappa, and delta receptors.
2. Codeine moderate painSide effect :constipationoral dose; 30-60mg 4-6hrs Max 240mg
3. Dihydrocodeine30-60mg 4-6hrsSide effect : Nausea, vomiting
4.Tramadolopioid effect + enhancement of seratogenic and
androgenic pathways.less opioid side effects.psychiatric rxns reportedDose 50-100mg 4-6hrs.
5. Pethidineprompt short term analgesia.less constipating than morphine less potent analgesic50-150mg 4-6hrs.sc or IM 25-100mg 4-6hrs.
Nonopioids Aspirin and acetaminophen are sometimes combined in
proprietary compounds. There is little evidence that either analgesia or antipyresis is
enhanced by this combination. A ceiling effect still occurs when the total amount of aspirin and
acetaminophen approaches 1 g. In pain following impacted third molar surgery, the combination
of 100 mg of enteric-coated diclofenac with 1000 mg of acetaminophen provides a superior analgesic effect than either drug alone or combination of 1000 mg of acetaminophen plus 60 mg of codeine.
Many of these combinations also contain caffeine. Caffeine is considered to be an analgesic adjuvant.
Caffeine doesn't seem to have analgesic effects when used alone. When 65to 100 mg of caffeine is combined with traditional analgeics (aspirin, acetaminophen, or ibuprofen), it improves their analgesic efficacy.
COMBINATION ANALGESICS
Opioid and Nonopioid Analgesics
Combination between NSAIDs or acetaminophen with opioids. NSAIDs/acetaminophen combat pain principally by interfering
with production of biochemical mediators that cause sensitization of nerve endings at the site of injury or spinal cord, whereas the opioids alter CNS perception and reaction to pain.
The clinical significance of the opioids is1. They provide additional analgesia beyond the ceiling effect
of the NSAID or acetaminophen alone2. They contribute a centrally mediated sedative effect.
The most effective combinations are those that use the optimal amount of an aspirin-like drug combined with the appropriate dose of an opioid analgesic.
Thank you